Stoke Therapeutics, Inc. (STOK)

NMS – Real Time Price. Currency in USD

32.49

-0.15 (-0.46%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

184M

37M

12M

Cost of goods sold

-4M

-5M

-4M

Gross Profit

180M

32M

Operating expenses (excl. COGS)

-201M

-133M

-119M

-113M

Operating Income

-21M

-101M

-115M

-104M

Non-operating income, total

14M

12M

10M

Pretax income

-7M

-89M

-105M

-101M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-7M

-89M

-105M

-101M

Stoke Therapeutics, Inc. (STOK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Stoke Therapeutics, Inc. (STOK)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Stoke Therapeutics, Inc. (STOK)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Stoke Therapeutics, Inc. (STOK)

Income Statement (Annual)

Income Statement (Annual)